Researchers evaluated response to the COVID-19 vaccine in patients undergoing hemodialysis in light of the frequency of vaccine hyporesponsiveness in immunocompromised patients.
Sweta GuptaContributing Writer
Sweta Gupta is a freelance writer and editor with more than 10 years of experience in media and publishing. She started her career at Wiley, editing textbooks on psychology, counseling, and social work. Afterward, she transitioned to working on professional content with Medscape Education, the largest US provider of continuing medical education programs. Most recently, she managed two websites for a clinician audience: Infectious Disease Advisor and Endocrinology Advisor. She is a graduate of Rutgers University and holds a BA in English literature and a minor in psychology.